Approach to hypertensive disorders in pregnancy: Clinical sciences

Last updated: January 30, 2025

Approach to hypertensive disorders in pregnancy: Clinical sciences

MPAN 690 Week 1 - Obstetrics & Gynecology

MPAN 690 Week 1 - Obstetrics & Gynecology

Anatomy of the breast
Anatomy clinical correlates: Breast
Approach to a breast mass and asymmetry: Clinical sciences
Benign breast conditions: Pathology review
Fibrocystic breast changes
Fibrocystic breast changes: Clinical sciences
Breast papilloma: Clinical sciences
Fibroadenoma: Clinical sciences
Breast cyst: Clinical sciences
Approach to nipple discharge: Clinical sciences
Approach to breast pain (mastalgia): Clinical sciences
Mastitis: Clinical sciences
Breast abscess: Clinical sciences
Breast cancer
Breast cancer screening: Clinical sciences
Breast cancer: Pathology review
Ductal carcinoma in situ: Clinical sciences
Invasive ductal carcinoma: Clinical sciences
Lobular carcinoma in situ: Clinical sciences
Invasive lobular carcinoma: Clinical sciences
Inflammatory breast cancer: Clinical sciences
Paget disease of the breast
Well-patient care (GYN): Clinical sciences
Cervix and vagina histology
Cervical cancer
Cervical cancer screening: Clinical sciences
Cervical dysplasia and cervical cancer: Clinical sciences
Cervical cancer: Pathology review
Vulvar dysplasia and vulvar cancer: Clinical sciences
Approach to vaginal discharge: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Sexually transmitted infection screening (Family medicine): Clinical sciences
Sexually transmitted infections: Vaginitis and cervicitis: Pathology review
Candida
Vulvovaginal candidiasis: Clinical sciences
Gardnerella vaginalis (Bacterial vaginosis)
Bacterial vaginosis: Clinical sciences
Trichomonas vaginalis
Vaginal trichomoniasis: Clinical sciences
Chlamydia trachomatis
Chlamydia trachomatis infection: Clinical sciences
Neisseria gonorrhoeae
Neisseria gonorrhoeae infection: Clinical sciences
Pelvic inflammatory disease
Pelvic inflammatory disease: Clinical sciences
Reversible contraception: Clinical sciences
Permanent contraception (sterilization): Clinical sciences
Emergency contraception: Clinical sciences
Approach to dysmenorrhea: Clinical sciences
Primary dysmenorrhea: Clinical sciences
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Approach to chronic pelvic pain (GYN): Clinical sciences
Uterine disorders: Pathology review
Uterine fibroid
Stress, urge, overflow, and mixed urinary incontinence (GYN): Clinical sciences
Preconception care: Clinical sciences
Pregnancy
Ectopic pregnancy
Ectopic pregnancy: Clinical sciences
Complications during pregnancy: Pathology review
Anemia in pregnancy: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Asthma in pregnancy: Clinical sciences
Cholestasis of pregnancy: Clinical sciences
Diabetes in pregnancy (GDM, T1DM, and T2DM): Clinical sciences
Approach to diabetes in pregnancy: Clinical sciences
Approach to hypertensive disorders in pregnancy: Clinical sciences
Chronic hypertension in pregnancy: Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Herpes simplex virus infection in pregnancy: Clinical sciences
Cytomegalovirus (CMV), parvovirus B19, varicella zoster, and toxoplasmosis infection in pregnancy: Clinical sciences
Alcohol, tobacco, cannabinoid, and substance use in pregnancy: Clinical sciences
Perinatal depression and anxiety: Clinical sciences
Hemoglobinopathies in pregnancy: Clinical sciences
Abdominal trauma in pregnancy: Clinical sciences
Early pregnancy loss: Clinical sciences
Miscarriage
Late-term and postterm pregnancy: Clinical sciences
Antepartum care (first trimester): Clinical sciences
Approach to first trimester bleeding: Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Approach to third trimester bleeding: Clinical sciences
Placenta previa and vasa previa: Clinical sciences
Placenta previa
Prelabor rupture of membranes: Clinical sciences
Preterm labor: Clinical sciences
Fetal growth restriction: Clinical sciences
Uterine stimulants and relaxants
Therapeutic and induced abortions: Clinical sciences
Menopause
Perimenopause, menopause, and primary ovarian insufficiency: Clinical sciences
Approach to postmenopausal bleeding: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Hypertension in pregnancy is a spectrum of disorders, all characterized by elevated blood pressure. These include chronic hypertension, gestational hypertension, preeclampsia without or with severe features, HELLP, and eclampsia.

Your first step in evaluating a patient who presents with a hypertensive disorder of pregnancy is to perform a CABCDE assessment along with a primary obstetric survey to determine if they’re stable or unstable.

If the patient is unstable, check for uncontrolled bleeding and control any hemorrhage, as severely elevated blood pressure may cause a placental abruption. Next, stabilize their airway, breathing, and circulation and consider intubation when appropriate.

Obtain IV access and continuously monitor maternal vital signs. As for the primary obstetric survey, monitor the fetal heart rate and contraction pattern; possibly test for rupture of amniotic membranes; and consider checking cervical dilation if indicated.

Here’s a clinical pearl! Urgent hypertension is defined as 160/110 or higher that persists after retake in 15 to 20 minutes; this requires antihypertensive medication to reduce the risk of maternal stroke.

Let’s take a look at stable patients. Alright, now that unstable patients are taken care of, let’s talk about stable patients. First, obtain a focused history and physical examination. This should include an accurate blood pressure measurement. A systolic blood pressure greater than or equal to 140, a diastolic blood pressure greater than or equal to 90, or both is considered abnormal during pregnancy. Once you have recognized the patient has elevated blood pressure, it’s time to investigate further; the first step is to assess the patient’s gestational age.

Let’s take a look when the patient is less than 20 weeks gestation.

If the patient is less than 20 weeks gestation, assess whether they have a history of hypertension prior to pregnancy. If the patient does report a history of hypertension, your diagnosis is chronic hypertension.

If the patient denies any history of hypertension, still consider a diagnosis of chronic hypertension and continue to monitor them closely throughout the remainder of the pregnancy.

If a second elevated blood pressure is recorded prior to 20 weeks of gestation, the patient meets the diagnostic criteria for chronic hypertension.

However, if they remain normotensive, the elevated blood pressure simply represents an isolated elevated blood pressure in pregnancy and not a true hypertensive disorder.

Okay, let’s shift our focus to patients who present with hypertension from 20 weeks of gestation through 12 weeks postpartum with abnormal blood pressure.

When a pregnant patient who is greater than or equal to 20 weeks gestation has abnormal blood pressure, monitor them closely to see if any repeat elevated blood pressure is noted.

If no repeat blood pressures are elevated, continue to monitor them at subsequent prenatal visits, though they do not meet the criteria for a true hypertensive disorder of pregnancy.

If a second elevated blood pressure is recorded, specifically a systolic pressure of at least 140, or a diastolic pressure of at least 90, or both, and it has been at least 4 hours since the first elevated measurement, you have diagnosed a hypertensive disorder of pregnancy.

Your next step is to order labs to help determine the specific disorder present. This will include a CBC, CMP, LDH, a urine protein to creatinine ratio, also known as P/C ratio, and possibly a 24-hour urine collection to measure total protein. A uric acid measurement can also be helpful in some cases.

Once these labs are sent, assess if the patient has any history of hypertension prior to pregnancy.

Let’s take a look when the patient reports no history of chronic hypertension either during or outside of pregnancy.

If your patient reports no history of chronic hypertension, consider either gestational hypertension or preeclampsia. To make your diagnosis, review lab results, specifically the urine P/C ratio to assess for proteinuria. Proteinuria is defined as a urine P/C ratio greater than or equal to 0.30, or a 24-hour urine protein with at least 300 mg of protein.

At the same time, assess for signs or symptoms of preeclampsia, which include new-onset headache, visual changes, right upper quadrant or epigastric pain, and possibly shortness of breath.

If all labs are normal, the urine P/C ratio is less than 0.30, and the patient is asymptomatic, your diagnosis is gestational hypertension.

Sources

  1. "Clinical practice update: Biomarker Prediction of Preeclampsia with Severe Features" Obstet Gynecol (2024)
  2. "ACOG committee opinion no. 828: Indications for outpatient antenatal fetal surveillance" Obstet Gynecol (2021)
  3. "ACOG committee opinion no. 743: Low-dose aspirin use during pregnancy" Obstet Gynecol (2018)
  4. "Practice advisory: Clinical guidance for the Integration of the findings of the chronic hypertension and pregnancy (CHAP) study" Obstet Gynecol (2022)
  5. "ACOG practice bulletin no. 222: Gestational hypertension and preeclampsia" Obstet Gynecol (2020)
  6. "ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy" Obstet Gynecol (2019)
  7. "Hypertension During Pregnancy" Curr Hypertens Rep (2020)
  8. "Practical guide for the management of hypertensive disorders during pregnancy" J Hypertens (2022)
  9. "Hypertensive Disorders in Pregnancy" Obstet Gynecol Clin North Am (2018)
  10. "Hypertensive disorders of pregnancy" BMJ (2023)
  11. "Hypertensive disorders of pregnancy" BMJ (2023)